Very well stated as always Bernard. I too agree the overhang of supply of shares owned by the creditors is unattractive to new investors and putting downward pressure on the PPS as shares hit the market.
I also agree there needs to be capital structure changes and PR asap. I still have not heard anything back from management about my investor inquiry.
I still firmly believe VHUB is undervalued and that the FDA regulation risk currently priced in is overstated, especially now that Trump will be president.
Still holding tight and hoping the next leg of the uptrend continues soon.
News 
Market Data 
Discover 
AI
